Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Trading Update

12 Dec 2014 15:00

RNS Number : 6804Z
Sopheon PLC
12 December 2014
 

SOPHEON PLC

("Sopheon" or the "Company")

 

TRADING UPDATE

 

Sopheon plc ("Sopheon"), the international provider of software and services that improve the return from innovation and new product development investments, issues a trading update.

 

We have previously highlighted that we expected performance in 2014 to be weighted to the back end of the year, consistent with the fourth quarter of 2013 which was the strongest in our history. Full year revenue visibility today stands at $17.4m compared to $15.0m at the time of the interims. Once again, meeting our commercial goals required a strong finish to the year, and our pipeline included several major license opportunities that would contribute to achieving them. As we approach the end of the year, orders are coming through, and this includes a record number of signatures expected from new customers, expanding our traditionally strong base of existing customers and underpinning future growth potential. However, it now looks increasingly likely that a number of the highest value orders will defer into the first quarter of 2015. As a result, revenue and profits for 2014 will fall below market expectations. As in previous years we will update shareholders on the year's actual performance in January. As we have often stated, the nature of our business makes it difficult to predict exactly when sales will get signed and be recognized. .

 

Since our interim statement, we have continued to push forward with operational and corporate developments. We released version 9.2 of our Accolade solution suite, which we believe provides the most comprehensive resource and portfolio planning and management capabilities in the market. We were delighted to hire Pieter Leijten, a senior business development director formerly at Infor. Pieter has a solid track record of overachievement in enterprise software sales and will lead our commercial team in Europe.

 

Since 2012 Sopheon has implemented a series of actions to improve its corporate profile. These include transferring our Amsterdam listing from Euronext to Alternext; a share consolidation to reduce both the number of shares in issue and the very large number of very small shareholders; a capital restructuring to substantively reduce accumulated losses on the balance sheet; and the securing of new facilities with Silicon Valley Bank. As previously announced, we have faced some challenges. Following our transfer, Euronext announced the closure of Alternext Amsterdam by the end of 2015; the board has not yet concluded on the most appropriate path to address this change. In addition, processing issues in the Netherlands that arose during the original share consolidation procedure led us to initiate a new procedure in recent weeks. The first step, a 500:1 consolidation, was implemented on 18 October and the shareholder meeting for the second step, a 1:500 subdivision, is scheduled for 19 December. Following the first step the directors made a number of share purchases, in Amsterdam, with the intention of providing support for the fractional entitlements that became available, and also underlining the board's continued confidence in the business.

 

A definition of how visibility is calculated was provided in our half- yearly report published on 28 August 2014. 

 

For further information contact:

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte Stranner / Victoria Bates

finnCap

+ 44 (0) 20 7220 0500

Heather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange, and on the Alternext Exchange in the Netherlands. For more information, please visit www.sopheon.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZLLFFZLFZFBV
Date   Source Headline
10th Jun 20217:00 amRNSAGM Statement
3rd Jun 20211:50 pmRNSIssue of Equity
2nd Jun 20217:00 amRNSSopheon Deployed Globally at The 3M Company
14th May 202110:11 amRNSGrant of Options / PDMR dealing
14th Apr 20217:00 amRNSLaunch of Accolade for Smart Products
9th Apr 20214:15 pmRNSIssue of Equity
31st Mar 20217:00 amRNSDirectorate Change
29th Mar 20212:30 pmRNSDirector Shareholdings
24th Mar 20217:00 amRNSFinal Results
3rd Mar 202111:02 amRNSHolding(s) in Company
2nd Mar 202112:12 pmRNSHolding(s) in Company
26th Feb 20214:20 pmRNSResult of Secondary Placing
26th Feb 20211:36 pmRNSProposed Secondary Placing
8th Feb 20214:30 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSSopheon extend innovation leadership with Simplot
25th Jan 20217:00 amRNSTrading Update
5th Nov 20207:00 amRNSRelease of Accolade version 13.2
12th Oct 20207:00 amRNSSeasoned Cloud & Industry Executive added to Team
9th Sep 20209:55 amRNSOrion Engineered Carbons works with Sopheon
1st Sep 202011:38 amRNSDirector Shareholdings
28th Aug 202012:39 pmRNSIssue of Equity
27th Aug 20207:00 amRNSInterim Results
30th Jul 20207:00 amRNSMondelez Partnership
13th Jul 202011:41 amRNSGrant of Options/PDMR Dealing
11th Jun 202011:28 amRNSResult of AGM
9th Jun 202012:00 pmRNSIssue of Equity & Director/PDMR Shareholding
28th May 20207:29 amRNSProgressive publishes new research
28th May 20207:00 amRNSNew Sopheon Release Integrating Microsoft Teams
15th May 202010:01 amRNSIssue of Equity
15th May 20207:00 amRNSAGM Notice and Update
3rd Apr 202011:17 amRNSDirector Shareholdings
25th Mar 20201:38 pmRNSIssue of Equity
19th Mar 20204:46 pmRNSIssue of Equity
19th Mar 20207:00 amRNSFinal Results
28th Jan 20209:05 amRNSSecond Price Monitoring Extn
28th Jan 20209:00 amRNSPrice Monitoring Extension
28th Jan 20207:00 amRNSTrading Update
10th Jan 20201:00 pmRNSIssue of Equity
11th Dec 20197:00 amRNSTrading Update
10th Oct 201912:00 pmRNSIssue of Equity
1st Oct 201912:00 pmRNSIssue of Equity
20th Sep 20194:45 pmRNSIssue of Equity
22nd Aug 20192:06 pmRNSSecond Price Monitoring Extn
22nd Aug 20192:01 pmRNSPrice Monitoring Extension
22nd Aug 201911:05 amRNSSecond Price Monitoring Extn
22nd Aug 201911:00 amRNSPrice Monitoring Extension
22nd Aug 20199:05 amRNSSecond Price Monitoring Extn
22nd Aug 20199:00 amRNSPrice Monitoring Extension
22nd Aug 20197:00 amRNSHalf-year Report
12th Aug 201910:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.